BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01746836-completion@plaintrial.com
DTSTAMP:20261027T150210Z
DTSTART;VALUE=DATE:20301231
SUMMARY:Ponatinib Hydrochloride as Second Line Therapy in Treating Patients
  With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to
  Imatinib Mesylate\, Dasatinib\, or Nilotinib — estimated completion dat
 e
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT01746836
URL:https://plaintrial.com/trial/NCT01746836
END:VEVENT
END:VCALENDAR